LBA Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$879K Buy
7,061
+350
+5% +$41.9K 0.46% 39
2016
Q4
$777K Buy
6,711
+930
+16% +$104K 0.43% 44
2016
Q3
$604K Buy
5,781
+80
+1% +$8.66K 0.34% 51
2016
Q2
$562K Buy
5,701
+600
+12% +$62.1K 0.32% 56
2016
Q1
$511K Sell
5,101
-630
-11% -$64.9K 0.3% 59
2015
Q4
$686K Buy
5,731
+141
+3% +$16.3K 0.4% 46
2015
Q3
$605K Buy
5,590
+1,190
+27% +$148K 0.38% 43
2015
Q2
$509K Buy
4,400
+130
+3% +$14.9K 0.32% 57
2015
Q1
$492K Buy
4,270
+525
+14% +$62.7K 0.31% 55
2014
Q4
$419K Buy
3,745
+1,200
+47% +$127K 0.28% 54
2014
Q3
$241K Sell
2,545
-125
-5% -$11.3K 0.17% 68
2014
Q2
$229K Buy
2,670
+170
+7% +$12.9K 0.19% 73
2014
Q1
$175K Buy
2,500
+700
+39% +$55.4K 0.14% 89
2013
Q4
$152K Buy
+1,800
New +$142K 0.13% 91

Other funds holding CELG

LBA Wealth Management's CELG Position: Q1 2017 in Review

LBA Wealth Management increased its Celgene Corp (CELG) stake by 5.2% in Q1 2017, buying an estimated $41.9K and bringing the position to 7,061 shares worth $879K. The position accounts for 0.46% of the portfolio, ranked #39.

LBA Wealth Management first reported a position in CELG in Q4 2013 and has held it in 14 quarters since. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • LBA Wealth Management held 7,061 shares of Celgene Corp worth $879K as of Q1 2017.
  • LBA Wealth Management bought 350 Celgene Corp shares in Q1 2017, an estimated $41.9K.
  • Celgene Corp made up 0.46% of LBA Wealth Management's portfolio in Q1 2017, its #39 holding.
  • LBA Wealth Management first reported a position in Celgene Corp in Q4 2013 and has held it in 14 quarters since.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.